Status:
COMPLETED
Improving Wisely - Polypharmacy
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Gordon and Betty Moore Foundation
Conditions:
Adverse Drug Event
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a randomized controlled trial that uses an audit and feedback intervention to alert primary care physicians who are outliers in one or more metrics related to high risk prescribing of particip...
Detailed Description
The investigators have developed five different metrics related to low-value (and/or high risk) prescribing habits based on guidelines. The five metrics are listed below. The investigators are using 1...
Eligibility Criteria
Inclusion
- Primary care physician
- Must be the primary care physician for at least ten Medicare patients
Exclusion
- None
Key Trial Info
Start Date :
January 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2021
Estimated Enrollment :
11000 Patients enrolled
Trial Details
Trial ID
NCT03857100
Start Date
January 4 2019
End Date
January 30 2021
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21287